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Enhancing cell energy and improving cell defense against stress with a
new cell energizer
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France
Oxidative stress and glycation are recognized as key factors in skin aging. Because
cell energizers can play an essential role in mitochondrial energy synthesis and
antioxidative stress protection, we were interested in developing a new cell
energyeinducing active ingredient (CE) and testing its effect on cultured cells and
ex vivo human skin. Total cellular ATP was evaluated in dose course studies and
showed that fibroblasts treated with the new CE for 3 hours exhibited an increase in
cellular ATP of 57%, 63%, and 42%, when treated with 0.5%, 1%, and 3% of CE,
respectively. Moreover, time course studies showed an increase in cell ATP of 17% at
1 hour, and 67% at 3 hours of treatment with 1% of CE. Interestingly, additional
studies showed that cells treated with 1% of CE exhibited a 30% decrease in protein
carbonylation. Similarly, after ultraviolet light stress with 50 mJ/cm2 of UVB light, or
after a stress with 2 mM of H2O2, a decrease of 20% in protein carbonylation was
found in CE-treated cells, in addition to a net decrease in the apoptosis marker
annexin V. Parallel studies were performed on ex vivo human skin, treated with 1%
of CE and then exposed to UVB irradiation with 100mJ/cm2, or to glycation stress
with 5 mM or 10 mM of methyl glyoxal. Hematoxylineeosin staining of ex vivo skin
samples treated with CE confirmed the above mentioned results by revealing a clear
protection of skin structure from UV and glycation damage, compared to the
untreated skin. These studies demonstrate the interesting antiaging effect that this
new active ingredient possesses by enhancing cell energy and ATP synthesis, and by
considerably improving cell protection from oxidative and glycation damage.FEBRUARYnsored by ISP.100% spoP208
A dermatologic evaluation of the tolerance and efficacy of a topical
antioxidant composition containing vitamins C, E, and ferulic acid
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Some of the major changes taking place in the skin as part of the aging process are
related to environmental factors, particularly solar exposure. Chronic exposure to
sunlight causes the generation of oxidative stress in the skin, resulting in impaired
mechanical and biophysical properties of the skin. Clinical symptoms include fine
lines and wrinkles, pigmentary changes, and the loss of skin elasticity and firmness.
Antioxidants have been shown to reduce the negative effects of ultraviolet light
damage by counteracting the generation of oxidative stress in the skin. The objective
of this study was to determine the efficacy and tolerance of an antioxidant product
in subjects with facial fine lines and wrinkles. Thirty-five female volunteers between
the ages of 30 and 60 years with facial fine lines and wrinkles and those with self-
perceived sensitive skin and frequent break-outs were enrolled in 24-week single-
center, controlled clinical usage study. During the course of the study, volunteers
applied the topical antioxidant composition containing vitamins C, E, and ferulic
acid to the face twice per day (each morning and night) after cleansing. Volunteers
were given cleanser and sunscreen (SPF 20) to substitute for their regular skin care
products until the study completion. At the baseline visit, volunteers were graded by
a dermatologist for fine lines, wrinkles, poor skin texture, lack of skin smoothness,
and firmness using a 9-point visual scale. Objective and subjective irritation
symptoms were assessed using a 9-point scale. Bioinstrumental measurements for
erythema, melanin, and skin firmness were also obtained at the baseline visit.
Volunteers returned at weeks 4, 8, 12, 18, and 24 for repeat grading and instrumental
measurements. Volunteers completed self-assessment questionnaires at each study
visit. Results demonstrated that the topical antioxidant composition containing
vitamins C, E, and ferulic acid is well tolerated and significantly improves fine lines,
skin texture, firmness, and smoothness of the skin.ponsored by L’Oreal.100% is s2008P209
Multi-center, clinical evaluation of a broad-spectrum sunscreen moistur-
izer containing a new photostable UVA/UVB complex for the treatment of
photodamaged facial skin
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The primary preventable cause of photoaging is exposure to ultraviolet A light (UVA)
radiation. This important wavelength emitted by the sun is present year-round at all
latitudes. At present, the majority of the sun protective products provide excellent
UVB protection with minimal UVA protection. New developments in raw material
science have led to the manufacture of novel ingredients that are able to provide
unprecedented photoprotection in the UVA spectrum. The most significant devel-
opment in cutaneous UVA protection was the discovery of ecamsule, a chemical
with the ability to enhance the stability of avobenzone while functioning as a
sunscreen. This study was designed to evaluate the effectiveness and tolerability of
this new SPF-15 moisturizer containing a new complex of broad-spectrum sun-
screen on facial photodamage. A 12-week, multicenter clinical study of females, aged
35 to 65 years, with mild to moderate periocular fine and coarse wrinkles and facial
dyschromia was conducted. The volunteers, Fitzpatrick skin classifications II to IV,
used the SPF-15 moisturizer every morning, and as needed during the day. A
multidimensional approach was used to assess moisturizer efficacy and tolerance at
baseline (pretreatment) and weeks 2, 4, 8, and 12 posttreatment. This included
clinical assessment, noninvasive bioengineering methods, digital imaging, and
subject self-assessment questionnaires. Clinical assessment included evaluation of
fine and coarse wrinkles, overall skin radiance, tactile roughness, and dyschromia.
Bioengineering methods included skin moisture measurements, brightness and
color, visco-elastic properties, and Silflo replica of the periocular roughness and
wrinkle properties. Multispectral digital imageswere taken of each side of the face to
evaluate visual efficacy. Self-assessment questionnaires were administered to eval-
uate the perceived efficacy and tolerance by the subjects. Statistically significant
improvements relative to baseline were observed over the course of the study for all
clinical assessment parameters, skin hydration, skin softness, skin elasticity, and skin
brightness. Image analysis of the periocular region revealed a skin smoothing effect
with diminished wrinkling. Visco-elastic properties improved both in skin softening
and elasticity. Digital images showed overall improvements in photodamage
properties. Objective and subjective symptoms of irritation assessment revealed
that the SPF-15 moisturizer was exceptionally well tolerated.nsored by L’Oreal.100% spoP210
High persistency of Glymatrix collagen in the correction of facial wrinkles
after 15 months
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Collagen has been used as a dermal corrective agent for nearly 30 years. In the past,
the major source of collagen (bovine), and an inability to efficiently remove
allergenic telipeptides, resulted in a constant proportion of patients suffering from
allergic reactions. In addition, early collagen lacked structural resemblance to native
human collagen, which led to higher biodegradation and decreased longlivety.
Through a patented purification and cross-linking process, the new generation
Glymatrix technology not only establishes a latticed collagen product of porcine
origin similar to human, but also one that is highly resistant to biodegradation and
one that does not require a skin test because of the extremely low risk of
hypersensitivity. Glymatrix collagen results from two, open-label, similarly designed,
clinical studieswere pooled to evaluate the 15-month persistency of this new dermal
filler in the correction of nasolabial folds. A total of 66male and female subjects were
followed for 12 months and 52 were evaluable at 15 months. The persistence
(change in the Modified Fitzpatrick Wrinkle Scale [MFWS] of[1) of the cosmetic
effect was rated through an evaluation of digital photographic images by three
blinded, independent physician assessors at the baseline visit (visit 4; before and
after correction) up to 12 months (visit 10), and 15 months (visit 11). Patients could
elect to continue in the study following their 12-month visit. More than 80% of
subjects met persistency criteria at 15 months. In addition, subject satisfaction with
their correction was 82% at 12 months and 62% at 15 months. The majority of
adverse events were of mild or moderate severity and were of the type typically
associated with dermal correction. No allergic reactions occurred. No subjects were
withdrawn from the study because of adverse events.rovided by ColBar LifeSciences, Ltd., aMember of the Johnson &
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